Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin htts on autophagy.

Carey N Lumeng1, Alan R Saltiel

  • 1Life Sciences Institute, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan 48109, USA. dumeng@umich.edu

Autophagy
|July 29, 2006
PubMed
Summary

Macroautophagy clears toxic polyglutamine (polyQ) proteins linked to neurodegenerative diseases like Huntington's Disease. New research reveals insulin signaling paradoxically promotes this crucial autophagic clearance of mutant protein aggregates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One drug, five targets.

Cell research·2026
Same author

Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover.

Nature·2026
Same author

Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Time-Restricted Eating Promotes Weight Loss and Favorable Changes in Adipose in Obesity: The TREAD Randomized Control Trial.

Obesity (Silver Spring, Md.)·2026
Same author

A nutrient-responsive AMPK/TBK1 circuit restricts adipocyte catabolism.

JCI insight·2026
Same author

TANK-binding kinase 1 protects against MASH progression via mitochondrial quality control.

Experimental & molecular medicine·2026

Area of Science:

  • Cellular Biology
  • Neuroscience
  • Genetics

Background:

  • Macroautophagy degrades polyglutamine (polyQ) tract-containing proteins, which arise from trinucleotide repeat expansion mutations.
  • These mutations cause neurodegenerative diseases, including Huntington's Disease, characterized by neuronal dysfunction from polyQ protein aggregates.
  • Understanding the regulation of autophagy in clearing these toxic aggregates is critical for therapeutic development.

Purpose of the Study:

  • To investigate novel regulators of autophagic processes involved in clearing mutant polyQ protein aggregates.
  • To elucidate the role of insulin signaling in the autophagy of disease-associated protein aggregates.

Main Methods:

  • Functional screening to identify proteins regulating autophagy of polyQ aggregates.
  • Analysis of insulin/insulin-like growth factor signaling pathways in the context of protein aggregate clearance.

Main Results:

  • A novel role for insulin signaling in promoting the autophagy of mutant protein aggregates was identified.
  • Evidence suggests insulin/insulin-like growth factor signaling can paradoxically promote the clearance of deleterious proteins.

Conclusions:

  • Insulin signaling pathways play a complex role in autophagy, potentially promoting the degradation of toxic polyQ aggregates.
  • These findings offer new insights into the mechanisms underlying neuroprotection in polyQ diseases and suggest potential therapeutic targets.

Related Experiment Videos